Vertex Pharmaceuticals (VRTX) Gets a Buy from Evercore ISI
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
bovnews17h
Vertex Pharmaceuticals Incorporated (VRTX) Stock Dilemma: A Drop That Has Everyone Talking—What’s the Real Story?
On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...
BioSpace19h
Massachusetts Tax Incentives for Moderna, Vertex and More Creating 1,155 Jobs
Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...
MyChesCo on MSN1d
Vertex, Inc. Set to Unveil Q3 2024 Financial Results with Live Call!
Vertex, Inc. (NASDAQ: VERX) will release its third quarter 2024 financial results before the market opens on Wednesday, November 6, 2024. A conference call to discuss the results is scheduled for 8:30 ...
stocknews1d
3 Pharma Stocks to Watch as Gene Therapy Gains Momentum
The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...
Vertex Pharmaceuticals’ Promising Market Position and Opioid-Sparing Solution Drive Buy Rating
Wells Fargo analyst Mohit Bansal has maintained their bullish stance on VRTX stock, giving a Buy rating yesterday. Mohit Bansal has given his ...
bovnews3d
Scotiabank Just Initiated Vertex Pharmaceuticals Incorporated (VRTX) Stock—What Does This Mean for Investors?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.26% of ...
New Century Financial Group LLC Reduces Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
New Century Financial Group LLC lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 25.1% during the 3rd quarter, according to its most recent disclosure with ...
BioSpace4d
5 Sickle Cell Therapies to Watch Following Pfizer’s Oxbryta Exit
In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy, BioSpace looks at five investigational drugs currently making their way through the pipeline.
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030
In that spirit, let's discuss two companies that meet those criteria: HCA Healthcare ( HCA 2.23%) and Vertex Pharmaceuticals ( VRTX -3.15%). Here's why their stocks could deliver better returns than ...
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
How richly valued are stocks right now? Legendary investor Warren Buffett has built Berkshire Hathaway's cash stockpile up to ...